The North America miRNA Tools and Services Market would witness market growth of 17.3% CAGR during the forecast period (2022-2028).
As a genetic component, miRNA is present in all eukaryotic cells. These are necessary for appropriate cell function because they are necessary for gene expression in living organisms. Since the objective of targeted research on RNA is to control and regulate gene expression, the development of RNA interference drugs and therapies is crucial for miRNA. Recent studies have found a connection between aberrant gene expression and chronic, incurable illnesses including AIDS and cancer.
Animals and plants both use microRNAs as post-transcriptional gene expression regulators. MiRNAs serve gene-regulatory roles by tying up with microRNA responsive elements (mREs) on targeted mRNAs, leading to notable modifications in a number of physiological and pathological processes. Therefore, identifying the miRNA-mRNA interaction of the target is essential to understanding the miRNA regulation network.
Typically, computational modelling accompanied by experimental verification of these miRNA-mRNA interactions is the optimal strategy for achieving this goal. Technology advancements have become a significant trend in microRNA research and have significantly advanced miRNA technology. In recent years, technological advancements in the crucial stages of miRNA expression profiling, validation, and target gene identification, have provided manufacturers and researchers with motivation to provide novel solutions.
In the USA, gastrointestinal cancer (GC) is the second most prevalent cancer among GI malignancies. Medical therapies at the diagnostic phase are essentially rendered useless due to the late and asymptomatic start of stomach cancer. However, the stepwise evolution of histological abnormalities from healthy gastric epithelium to gastric metaplasia to gastritis to dysplasia to carcinoma offers a period of opportunity for more modern biomarkers and newer detection methods to stop the progression of GC.
The US market dominated the North America miRNA Tools and Services Market by Country in 2021; thereby, achieving a market value of $255.7 million by 2028. The Canada market is experiencing a CAGR of 20% during (2022 - 2028). Additionally, The Mexico market would exhibit a CAGR of 18.9% during (2022 - 2028).
Based on Technology, the market is segmented into qRT-PCR, Extraction Tools, NGS, Microarray, Functional Analysis Tools and Others. Based on End User, the market is segmented into Research & Academic Institutes, IVD, Pharma & Biotech Companies and CROs. Based on Product & Services, the market is segmented into Research Tools and Services. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global miRNA Tools and Services Market is Estimated to reach $939.8 Million by 2028, at a CAGR of 17.8
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., Qiagen N.V., New England BioLabs, Inc., Promega Corporation, GeneCopoeia and Norgen Biotek Corp.
By Technology
By End User
By Product & Services
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
